Latest news
122 Adjuvant Ribociclib (RIB) Plus Nonsteroidal Aromatase Inhibitor (NSAI) in Patients With HR+/HER2− Early Breast Cancer (EBC): NATALEE 5-Year Outcomes - CancerNetworkCancerNetwork · Tue, 04 Aug 2026 22:00:00 GMTStaff at NSAI to take industrial action over one worker redundancy - The Irish TimesThe Irish Times · Thu, 30 Jul 2026 07:00:00 GMTUnite members in NSAI to take industrial action - RTE.ieRTE.ie · Thu, 30 Jul 2026 07:00:00 GMT